BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20649711)

  • 1. Incidence rate of mycosis fungoides in Isfahan (Iran).
    Salehi M; Azimi Z; Fatemi F; Rajabi P; Kazemi M; Amini G
    J Dermatol; 2010 Aug; 37(8):703-7. PubMed ID: 20649711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of primary cutaneous T-cell lymphoma in Norway.
    Saunes M; Nilsen TI; Johannesen TB
    Br J Dermatol; 2009 Feb; 160(2):376-9. PubMed ID: 18808419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycosis fungoides in Norway 1960-80. A retrospective study.
    McFadden N; Nyfors A; Tanum G; Granholt A; Helme P; Kavli G
    Acta Derm Venereol Suppl (Stockh); 1983; 109():1-13. PubMed ID: 6589937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycosis fungoides in Arab children and adolescents: a report of 36 patients from Kuwait.
    Nanda A; AlSaleh QA; Al-Ajmi H; Al-Sabah H; Elkashlan M; Al-Shemmari S; Demierre MF
    Pediatr Dermatol; 2010; 27(6):607-13. PubMed ID: 21138468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
    Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
    J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The head and neck manifestations of mycosis fungoides.
    Brennan JA
    Laryngoscope; 1995 May; 105(5 Pt 1):478-80. PubMed ID: 7760661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
    Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis in Isfahan, Iran.
    Saadatnia M; Etemadifar M; Maghzi AH
    Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of mycosis fungoides.
    Weinstock MA
    Semin Dermatol; 1994 Sep; 13(3):154-9. PubMed ID: 7986682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of mycosis fungoides in patients in the Southeast of England.
    Morales MM; Putcha V; Evans HS; Olsen J; Llopis A; Møller H
    Dermatology; 2005; 211(4):325-9. PubMed ID: 16286740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
    Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
    Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational exposures and mycosis fungoides. A European multicentre case-control study (Europe).
    Morales-Suárez-Varela MM; Olsen J; Johansen P; Kaerlev L; Guénel P; Arveux P; Wingren G; Hardell L; Ahrens W; Stang A; Llopis A; Merletti F; Aurrekoetxea JJ; Masala G
    Cancer Causes Control; 2005 Dec; 16(10):1253-9. PubMed ID: 16215876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of primary cutaneous lymphomas in Tehran, Iran (1998-2004).
    Manuchehri HM; Rakhshan M
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):758-60. PubMed ID: 16836523
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycosis fungoides two decades after exposure to sulphur mustard: a follow-up of 1100 victims.
    Emadi SN; Shiri M; Shiri Z; Emadi SE; Mortazavi H; Nikoo A; Akhavan-Moghaddam J
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):432-437. PubMed ID: 27699871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papular mycosis fungoides: two new cases of a recently described clinicopathological variant of early mycosis fungoides.
    Martorell-Calatayud A; Botella-Estrada R; Sanmartín-Jimenez O; Requena C; Guillén-Barona C; Sangüeza OP
    J Cutan Pathol; 2010 Mar; 37(3):330-5. PubMed ID: 19737334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation.
    Kamarashev J; Theler B; Dummer R; Burg G
    Int J Dermatol; 2007 Sep; 46(9):930-5. PubMed ID: 17822495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
    Tan ES; Tang MB; Tan SH
    Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.